Pharma Industrial India - Professional magazine for pharma industry suppliers and lab technology

Biofabri and Bharat Biotech Sign Technology Transfer Deal for MTBVAC

Biofabri and Bharat Biotech have entered into a technology transfer agreement to enable end-to-end manufacturing of the MTBVAC tuberculosis vaccine candidate, supporting global efforts to expand access to new TB prevention options, particularly in high-burden, low- and middle-income countries.

Market | 24/12/2025 | By News Bureau

Pharma Industrial Magazine

All magazines | Subscribe

Interviews

Shoeb Kurawadwala on Innovations, Digitalisation, and Future Growth of CN Water

Shoeb Kurawadwala, Founder and Managing Director, CN Water

In an era where pharmaceutical quality and regulatory compliance are under constant scrutiny, the role of water treatment in drug manufacturing has never been more critical. In this interview, Shoeb Kurawadwala, Fou...

Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)

India’s MedTech industry stands at a pivotal point of growth and transformation. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), explains his vision to Pharma Industrial I...

How Freudenberg Filtration Helps Pharma Companies Meet Compliance Standards

Chinmay Korad, Country Head, Pharma, Freudenberg Filtration Technologies India

In an exclusive interview with Pharma Industrial India, Chinmay Korad, Country Head – Pharma, Freudenberg Filtration Technologies India, discusses the company’s key product lines, its growth and expansio...

All interviews

Articles

Shimadzu Leads Smarter Analytics Through AI-Led Innovations in Chromatography and Mass Spectrometry

Shimadzu is incorporating Analytical Intelligence (AI) and advanced software tools to streamline chromatography and mass spectrometry workflows, reduce manual intervention, and support regulatory-compliant method de...

Pharma 2025: The Year of Convergence, Accountability, and Intelligent Acceleration

This year, pharma industry finds itself not in a state of flux, but of fusion—where technology, data, and human purpose converge to redefine the very fabric of healthcare innovation. No longer confined to incr...